ISU Abxis Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 185

Employees

  • Stock Symbol
  • 086890

Stock Symbol

  • Share Price
  • $2.38
  • (As of Tuesday Closing)

ISU Abxis General Information

Description

ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

Contact Information

Website
www.abxis.com
Formerly Known As
Petagen Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Global R&D Center Building C, 4th, 5th Floor
  • 22 Daewangpangyo-ro 712beon-gil
  • Seongnam, Gyeonggi 13488
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Corporate Office
  • Global R&D Center Building C, 4th, 5th Floor
  • 22 Daewangpangyo-ro 712beon-gil
  • Seongnam, Gyeonggi 13488
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ISU Abxis Stock Performance

As of 17-Nov-2026, ISU Abxis’s stock price is $2.38. Its current market cap is $97M with 40.8M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.38 $2.31 $1.94 - $4.32 $97M 40.8M 68.7K -$0.15

ISU Abxis Financials Summary

As of 30-Jun-2026, ISU Abxis has a trailing 12-month revenue of $35.2M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 94,995 140,365 104,397 147,296
Revenue 35,170 39,822 44,164 41,535
EBITDA 555 (479) 5,170 13,228
Net Income (5,637) (7,503) 10,787 2,762
Total Assets 99,926 110,343 108,781 160,427
Total Debt 14,069 20,422 29,784 87,884
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ISU Abxis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ISU Abxis‘s full profile, request access.

Request a free trial

ISU Abxis Patents

ISU Abxis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023386332-A1 Antibody binding specifically to asm protein Pending 25-Nov-2022
EP-4624495-A1 Antibody binding specifically to asm protein Pending 25-Nov-2022
US-20260201064-A1 Antibody binding specifically to asm protein Pending 25-Nov-2022
WO-2024111990-A1 Antibody binding specifically to asm protein Inactive 25-Nov-2022
AU-2022279876-A1 Antibody specifically binding to asm protein Active 27-May-2021 G01N33/573
To view ISU Abxis’s complete patent history, request access »

ISU Abxis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ISU Abxis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ISU Abxis‘s full profile, request access.

Request a free trial

ISU Abxis ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view ISU Abxis’s complete esg history, request access »

ISU Abxis FAQs

  • When was ISU Abxis founded?

    ISU Abxis was founded in 2001.

  • Where is ISU Abxis headquartered?

    ISU Abxis is headquartered in Seongnam, South Korea.

  • What is the size of ISU Abxis?

    ISU Abxis has 185 total employees.

  • What industry is ISU Abxis in?

    ISU Abxis’s primary industry is Drug Discovery.

  • Is ISU Abxis a private or public company?

    ISU Abxis is a Public company.

  • What is ISU Abxis’s stock symbol?

    The ticker symbol for ISU Abxis is 086890.

  • What is the current stock price of ISU Abxis?

    As of 17-Nov-2026 the stock price of ISU Abxis is $2.38.

  • What is the current market cap of ISU Abxis?

    The current market capitalization of ISU Abxis is $97M.

  • What is ISU Abxis’s current revenue?

    The trailing twelve month revenue for ISU Abxis is $35.2M.

  • What is ISU Abxis’s annual earnings per share (EPS)?

    ISU Abxis’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process